TABLE 3.
Characteristic | B. abortus S19a | B. abortus 45/20 | B. abortus RB51 | B. ovis REO 198 | Reference |
---|---|---|---|---|---|
Invasiveness to host and cellsb | |||||
Ovine infection | Moderate | Moderate | Moderate | Severe | 8, 12, 17 |
Bovine infection | Moderate | Moderate | Moderate | None | 1, 8, 21 |
No. (%) of bacterium-associated cells after 2 h | 75 | 98 | 100 | 12 | 22, 23, 27 |
No. of adherent bacteria per cell after 2 h | 4 | 40 | 38 | 4 | 22, 23, 27 |
No. of intracellular bacteria per cell after 2 h | 1–2 | 20 | 18 | 0–1 | 22, 23, 27 |
No. of CFU within cells at 48 h | 5 × 105 | 6.2 × 106 | NDc | 0 | 22, 23, 27 |
No. (%) of infected cells dead at 48 h | 0 | 73 | ND | 0 | 22, 23 |
Bacteria outside lysosomes | + | ++ | ND | − | 22, 23, 27 |
Skin reaction of B. melitensis-infected animals | Positive | Positive | ND | Negative | 13, 26 |
OM properties | |||||
Reactivity with polyclonal anti-B. canis R-LPS | Total | Total | Total | Partial | 18, unpublished data |
Access to surface R epitopes | + | ++++ | ++++ | ++++ | 4 |
Estimated no. of anti-O chain gold conjugate particles per bacterial cell | 3,000–5,000 | 0–12 | 0 | 0 | 4, 10, 26, this work |
Heterogeneity of R-LPS in SDS-PAGE (no. of bands) | 1 | 4 | 3 | 1 | 10, 26 |
OM protein 25 | Complete | Complete | Complete | Truncated | 4, 7 |
OM protein 31 | Absent | Absent | Absent | Present | 4, 29 |
Sensitivity to hydrophobic antibiotics | + | ++ | ND | ++++ | 15 |
Maximal uptake of NPN (s) | 200 | 200 | 200 | 10 | This work |
Binding of polymyxin B by LPS | + | ++ | ++ | ++++ | 16, this work |
Sensitivity to cationic peptides | + | ++ | ++ | ++++ | 16, this work |
This is an attenuated vaccine strain. Virulent B. abortus 2308 induces severe infections, penetrates cells at an efficiency of close to 100%, evades lysosomes, and replicates within cells (23). LPS preparations from smooth Brucella contain close to 10% of rough-type LPS displayed in a single band in SDS-PAGE (10). −, absent; +, present in <25%; ++, present in >25% to <50%; ++++, present in >75%.
Tested in human epithelial HeLa cells.
ND, not done with RB51.